These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

493 related items for PubMed ID: 27156619

  • 21. Characterization of pncA mutations in multi-drug and pyrazinamide resistant Mycobacterium tuberculosis isolates cultured from Queensland migrants and Papua New Guinea residents.
    Pandey S, Lavu E, Congdon J, Moke R, Bainomugisa A, Coulter C.
    Tuberculosis (Edinb); 2018 Jul; 111():109-113. PubMed ID: 30029894
    [Abstract] [Full Text] [Related]

  • 22. High prevalence of phenotypic pyrazinamide resistance and its association with pncA gene mutations in Mycobacterium tuberculosis isolates from Uganda.
    Naluyange R, Mboowa G, Komakech K, Semugenze D, Kateete DP, Ssengooba W.
    PLoS One; 2020 Jul; 15(5):e0232543. PubMed ID: 32413052
    [Abstract] [Full Text] [Related]

  • 23. Characterization of katG, inhA, rpoB and pncA in Mycobacterium tuberculosis isolates from MDR-TB risk patients in Thailand.
    Suthum K, Samosornsuk W, Samosornsuk S.
    J Infect Dev Ctries; 2020 Mar 31; 14(3):268-276. PubMed ID: 32235087
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Pyrazinamide resistance and pncA mutations in drug resistant Mycobacterium tuberculosis clinical isolates from Myanmar.
    Ei PW, Mon AS, Htwe MM, Win SM, Aye KT, San LL, Zaw NN, Nyunt WW, Myint Z, Lee JS, Aung WW.
    Tuberculosis (Edinb); 2020 Dec 31; 125():102013. PubMed ID: 33142220
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Surveillance of pyrazinamide susceptibility among multidrug-resistant Mycobacterium tuberculosis isolates from Siriraj Hospital, Thailand.
    Jonmalung J, Prammananan T, Leechawengwongs M, Chaiprasert A.
    BMC Microbiol; 2010 Aug 20; 10():223. PubMed ID: 20727143
    [Abstract] [Full Text] [Related]

  • 28. Characterisation of pyrazinamide-resistant Mycobacterium tuberculosis strains isolated in Poland and Germany.
    Napiórkowska A, Rüsch-Gerdes S, Hillemann D, Richter E, Augustynowicz-Kopeć E.
    Int J Tuberc Lung Dis; 2014 Apr 20; 18(4):454-60. PubMed ID: 24670702
    [Abstract] [Full Text] [Related]

  • 29. Genotypic drug resistance using whole-genome sequencing of Mycobacterium tuberculosis clinical isolates from North-western Tanzania.
    Kidenya BR, Mshana SE, Fitzgerald DW, Ocheretina O.
    Tuberculosis (Edinb); 2018 Mar 20; 109():97-101. PubMed ID: 29559127
    [Abstract] [Full Text] [Related]

  • 30. Characterization of pyrazinamide resistance in consecutive multidrug-resistant mycobacterium tuberculosis isolates in sweden between 2003 and 2015.
    Mansjo M, Werngren J, Hoffner S.
    Int J Mycobacteriol; 2017 Mar 20; 6(2):156-161. PubMed ID: 28559517
    [Abstract] [Full Text] [Related]

  • 31. Epidemiologic Correlates of Pyrazinamide-Resistant Mycobacterium tuberculosis in New York City.
    Verdugo D, Fallows D, Ahuja S, Schluger N, Kreiswirth B, Mathema B.
    Antimicrob Agents Chemother; 2015 Oct 20; 59(10):6140-50. PubMed ID: 26195530
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Characterisation of the pncA gene in Mycobacterium tuberculosis isolates from Gauteng, South Africa.
    Bishop KS, Blumberg L, Trollip AP, Smith AN, Roux L, York DF, Kiepiela P.
    Int J Tuberc Lung Dis; 2001 Oct 20; 5(10):952-7. PubMed ID: 11605890
    [Abstract] [Full Text] [Related]

  • 39. Drug-resistance characteristics, genetic diversity, and transmission dynamics of multidrug-resistant or rifampicin-resistant Mycobacterium tuberculosis from 2019 to 2021 in Sichuan, China.
    Gao W, Wang W, Li J, Gao Y, Zhang S, Lei H, He L, Li T, He J.
    Antimicrob Resist Infect Control; 2024 Oct 14; 13(1):125. PubMed ID: 39396971
    [Abstract] [Full Text] [Related]

  • 40. [Phenotypic characterization of pyrazinamide-resistant Mycobacterium tuberculosis isolated in Poland].
    Napiórkowska A, Augustynowicz-Kopeć E, Zwolska Z.
    Pneumonol Alergol Pol; 2010 Oct 14; 78(4):256-62. PubMed ID: 20665445
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.